Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis.
Yang S, Tang X, Wang L, Ni C, Wu Y, Zhou L, Zeng Y, Zhao C, Wu A, Wang Q, Xu X, Wang Y, Chen R, Zhang X, Zou L, Huang X, Wu J.
Yang S, et al. Among authors: zou l.
Int J Mol Sci. 2022 Dec 17;23(24):16137. doi: 10.3390/ijms232416137.
Int J Mol Sci. 2022.
PMID: 36555781
Free PMC article.